Codify — Article

California SB 144: Broad public‑health and licensure changes tied to 2028 Olympics and state immunization authority

Creates temporary licensure carve‑outs for Olympic medical teams, shifts immunization policymaking to the state department, adjusts lab and licensing fees, and establishes an Abortion Access Fund.

The Brief

SB 144 is a broad health‑policy omnibus that stitches together temporary event‑specific licensing carve‑outs for the 2028 Los Angeles Olympic and Paralympic Games with a set of lasting changes to California’s public‑health governance. It creates narrow exemptions allowing out‑of‑state, territorial, and international health professionals and EMS personnel invited by the Los Angeles Organizing Committee to provide services at sanctioned game sites, adds a mechanism for team representatives to consent for incapacitated athletes, and sets explicit authorization windows tied to the games.

Beyond the Olympics carve‑outs, the bill reassigns several technical authorities: it makes the State Department of Public Health (CDPH) the baseline authority for immunization recommendations (anchored to federal recommendations as of January 1, 2025) and allows CDPH to modify those recommendations without going through full APA rulemaking; it revises fee‑setting for clinical laboratories and tissue banks to a cost‑recovery model; raises and authorizes adjustments to genetic counseling fees; creates an Abortion Access Fund with a temporary mechanism to transfer Exchange‑held segregated funds to it; and implements multiple programmatic and reporting changes across Medi‑Cal, Covered California, and behavioral health initiatives. These shifts reallocate decision‑making power and funding levers that compliance officers, plan actuaries, and health program managers will need to operationalize.

At a Glance

What It Does

SB 144 temporarily exempts invited out‑of‑jurisdiction health practitioners and EMS personnel from California licensing requirements to provide services at LAOC‑sanctioned 2028 Olympic and Paralympic sites and empowers team representatives to consent for certain incapacitated athletes. It also makes CDPH the state’s primary immunization recommender (using a Jan 1, 2025 federal baseline) and permits CDPH to modify that baseline without full APA rulemaking, changes lab and tissue bank fee methodology to cover estimated program costs, and establishes an Abortion Access Fund with transfers from Exchange segregated accounts for a limited period.

Who It Affects

The bill directly affects visiting health professionals (physicians, nurses, therapists, EMS personnel) invited to provide services at Olympic sites; California licensed clinical laboratories, tissue banks, and genetic counselors (fee changes); health plans and Covered California (payments for state‑mandated gender‑affirming care and temporary transfers to the Abortion Access Fund); CDPH and DHCS (new authorities, publication duties, and program changes); and athletes, teams, and patients who rely on Medi‑Cal and state immunization policy.

Why It Matters

SB 144 centralizes immunization policy authority at the state level and creates event‑specific licensure flexibility for a major international sporting event—both precedent‑setting moves. For health plan compliance and public‑health administration, it changes who sets immunization guidance, how labs are funded, how certain benefits are paid for, and introduces a new state‑level abortion funding mechanism with temporary plan contribution requirements.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

SB 144 bundles temporary, event‑driven licensure exceptions with enduring administrative and programmatic changes across California’s health system. For the 2028 Los Angeles Olympic and Paralympic Games the bill creates a narrow, time‑limited exemption so that health care practitioners licensed in another U.S. state, territory, or in another country can provide professional services at sites designated by the Los Angeles Organizing Committee (LAOC), provided the practitioners were invited by LAOC and the committee supplies specified identifying information to the Director of Consumer Affairs.

The exemption applies only while the practitioner is providing services at the committee’s invitation and only during the sanctioned timeframe. The bill also allows an official team representative to consent to treatment for a team member who cannot consent due to age, disability, or injury when a parent, guardian, or legal representative is not available, and it makes clear that in emergencies parental consent is not required.

For emergency medical services, SB 144 authorizes out‑of‑state EMTs and paramedics to operate at LAOC‑sanctioned sites if the Emergency Medical Services Authority’s chief medical officer authorizes them based on system needs, qualifications, and public safety. That authorization carries a specified effective window tied to the games and includes a statutory prohibition on liability for acts or omissions taken in good faith while performing authorized services.On immunization policy, the bill sets the recommendations in force on January 1, 2025 (USPSTF, ACIP, HRSA) as the baseline.

It then gives CDPH explicit authority to modify or supplement that baseline and to publish recommended lists and updates without following the full Administrative Procedure Act rulemaking path. As a corollary, the bill changes several cross‑statutory references that previously pointed to the federal Advisory Committee on Immunization Practices (ACIP) so that practitioners and institutions now follow CDPH recommendations for permitted immunization prescribing and program requirements.

Where federal approvals or federal financial participation are required (for example, Medi‑Cal coverage), the bill ties implementation to those federal conditions.SB 144 also restructures fee methodology for clinical laboratory licensing and tissue banks, moving from a statutory formula based on appropriations and federal funds to an annual department determination designed to cover estimated licensing program costs; it revises specific application and renewal fees for clinical personnel and raises the statutory base genetic counselor fee while permitting the department to increase fees up to a cap after stakeholder input. Financially, the bill requires Covered California to make payments to issuers to defray state‑mandated gender‑affirming benefits for plan years beginning January 1, 2026, subject to legislative appropriation, and establishes a continuously appropriated Abortion Access Fund, with a temporary mechanism—through Director of Department of Managed Health Care orders—to move a capped portion of Exchange segregated account balances into that fund between fiscal years 2025–26 and 2028–29.

Finally, the bill repeals or delays a number of existing reporting requirements across DHCS and other agencies, extends a limited LEP medical interpretation pilot timetable by one year, and makes several technical Medi‑Cal timing and eligibility adjustments, including delaying certain premium start dates for some noncitizen populations and preserving specified exemptions for foster youth and nonminor dependents.

The Five Things You Need to Know

1

The bill authorizes out‑of‑state, territorial, or international health practitioners invited by the Los Angeles Organizing Committee to practice at LAOC‑sanctioned Olympic/Paralympic sites only while invited and only during the sanctioned window.

2

CDPH’s immunization recommendations default to the federal USPSTF/ACIP/HRSA lists as of January 1, 2025, but CDPH may modify or supplement that baseline and publish updates without full APA rulemaking.

3

Emergency medical technicians licensed elsewhere can be authorized by the EMS Authority’s chief medical officer to provide EMS at sanctioned game sites; authorizations run May 15, 2028 through September 15, 2028 unless withdrawn, and statute limits liability for good‑faith acts.

4

The bill replaces statutorily prescribed lab fee escalation formulas with an annual CDPH adjustment designed to recover estimated licensing program costs and revises tissue bank and clinical laboratory personnel fees accordingly.

5

SB 144 establishes a continuously appropriated Abortion Access Fund and requires, from FY 2025–26 through FY 2028–29, health plans that offer qualified Exchange plans to transfer up to specified capped amounts from their segregated accounts to that fund at the Director of Managed Health Care’s order.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Part 1 (Olympic and Paralympic practitioner exemptions)

Temporary licensure carve‑outs for invited Olympic health practitioners and consent rules

This section exempts health care practitioners licensed in another state, territory, or country from certain California healing‑arts licensure, certification, or registration requirements when they provide services at Olympic and Paralympic activities after being invited by the Los Angeles Organizing Committee (LAOC). The exemption is strictly conditional: LAOC must provide specified practitioner information to the Director of Consumer Affairs and the practitioner may practice only during the committee‑sanctioned period and only while acting at the committee’s invitation. The section also authorizes an official team representative to consent for an incapacitated team member when a parent or legal guardian cannot be reached and confirms that parental consent is unnecessary for emergency care.

Part 2 (EMS authorization and liability for Olympic sites)

EMS cross‑jurisdictional authorization and limited liability

The bill directs the Emergency Medical Services Authority’s chief medical officer to authorize out‑of‑state EMT‑I/II/Paramedics to provide EMS at LAOC‑sanctioned locations, based on system needs, LAOC requirements, qualifications, and public safety. Authorizations are timebound (May 15 to September 15, 2028) unless withdrawn earlier. The provision includes an express prohibition of liability for authorized EMS personnel acting in good faith while providing services under the authorization, insulating those providers from state licensure exposure for the limited period.

Part 3 (State immunization baseline and CDPH rulemaking exemption)

CDPH baseline immunization list and streamlined modification authority

SB 144 fixes the baseline set of recommended immunizations, items, and services to the USPSTF, ACIP, and HRSA lists that were in effect on January 1, 2025, and authorizes CDPH to modify or supplement that baseline. Critically, CDPH may make such modifications and publish recommendations without undergoing the full rulemaking procedures of the Administrative Procedure Act. The department must publish the recommendations and any updates, which effectively moves primary operational authority for state immunization guidance from federal advisory bodies to CDPH while using the 2025 federal lists as a starting point.

6 more sections
Part 4 (Immunization prescribing alignment)

Shifts practitioner immunization authority to align with CDPH recommendations

The bill changes multiple statutes that previously authorized dentists, optometrists, pharmacists, and podiatrists to prescribe or administer immunizations in compliance with federal/ACIP recommendations so that those licensees must now act consistent with CDPH recommendations. This aligns on‑the‑ground clinical authority — what measurers practitioners may administer independently — with the state’s published guidance rather than with federal advisory statements alone.

Part 5 (Clinical laboratory and tissue bank fee reforms)

Replaces statutory fee formulas with department cost‑recovery adjustments

SB 144 removes the prior fee‑adjustment formulas tied to Budget Act percentage changes and federal funding levels for clinical laboratories and field services. In their place the State Department of Public Health must adjust fees annually to cover estimated licensing program costs. The bill applies that methodology to tissue bank licensing (previously a $950 baseline adjusted by Budget Act) and revises application, registration, and license fees for clinical laboratories and personnel; operationalizing this will require new departmental budgeting, fee‑modeling, and stakeholder communications.

Part 6 (Covered California and gender‑affirming care payments)

Exchange payments to defray state‑mandated gender‑affirming benefits

If a qualified health plan must cover state‑mandated gender‑affirming benefits deemed beyond federal essential health benefits, the bill requires Covered California to provide payments to issuers to offset those costs for plan years beginning on or after January 1, 2026, but only upon legislative appropriation. The Health Care Affordability Reserve Fund may be tapped for these payments subject to appropriation, creating a state‑level backstop for plan cost exposure tied to state benefit mandates.

Part 7 (Abortion Access Fund and temporary transfers)

Creates Abortion Access Fund and temporary transfers from Exchange segregated accounts

SB 144 establishes a continuously appropriated Abortion Access Fund to finance abortion services and grants. From FY 2025–26 through FY 2028–29 the Director of the Department of Managed Health Care may order plans that offer qualified Exchange plans to transfer funds from their segregated accounts to the Abortion Access Fund—up to the amount previously funded by the Exchange but capped at a specified percentage of the account ending balance—and those transfers must be completed by the plan. The bill also makes contracts, grants, and related information distributed from the fund exempt from public disclosure, which affects transparency and oversight.

Part 8 (Genetic counselor fees and misc. program changes)

Increases genetic counselor fees, extends LEP pilot, and repeals select reporting duties

The bill raises the statutory license and renewal fee for genetic counselors from up to $200 to $300 and authorizes CDPH to adjust fees up to $500 after soliciting stakeholder input. SB 144 extends an LEP medical‑interpretation pilot project and availability of previously appropriated funds by one year. It also repeals or removes several statutory reporting requirements across DHCS and other former departmental duties — trimming periodic legislative reporting on certain transitions, pilot evaluations, and managed‑care activities.

Part 9 (Medi‑Cal technical and eligibility adjustments)

Coverage alignment, asset disregard timing, and Medi‑Cal premium timing changes

SB 144 requires vaccines and immunizations covered by Medi‑Cal to align with multiple professional recommendations and with CDPH modifications, contingent on federal financial participation and approvals. It clarifies timing for implementation conditions already in law (for example, that certain asset‑disregard system programming and implementation cannot occur before January 1, 2026) and delays the start date for specified monthly premiums for individuals without satisfactory immigration status until no sooner than July 1, 2027, while exempting certain nonminor dependents and foster youth from these premium and service limitations.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Visiting Olympic and Paralympic medical teams and individual practitioners — they can provide care at LAOC‑sanctioned sites without obtaining full California licensure for the short event window, simplifying staffing and cross‑border deployment.
  • Athletes and team members — gain expedited access to invited clinical and emergency care on‑site, plus an explicit consent pathway through official team representatives when guardians are unavailable.
  • Covered California issuers offering qualified health plans — the Exchange is authorized to make payments to defray state‑mandated gender‑affirming benefits (subject to appropriation), reducing immediate plan liability for those mandated benefits.
  • Organizations and providers funded through the Abortion Access Fund — receive a new, continuously appropriated revenue source and a temporary directed transfer mechanism that can expand funding for abortion services and grants.
  • State public‑health officials at CDPH — gain decisional authority to set and update immunization recommendations for California without full APA proceedings, streamlining their ability to tailor guidance to state needs.

Who Bears the Cost

  • State Department of Public Health — must absorb new operational duties: publishing recommendations, modeling and setting cost‑recovery fees for labs/tissue banks, and administering increased fee frameworks and stakeholder processes.
  • Clinical laboratories, tissue banks, and certain clinical personnel — face restructured fees set to recover licensing program costs, which may increase compliance budgets and accounting complexity.
  • Health care service plans that participate in the Exchange — for FY 2025–26 through FY 2028–29 may be required by Director order to transfer funds from segregated Exchange accounts to the Abortion Access Fund up to capped amounts, and failure to comply can carry criminal penalties for willful violations.
  • Local educational agencies and schools — must follow CDPH immunization recommendations where statutes previously referenced ACIP; some of these changes create state‑mandated local program obligations.
  • Legislative and oversight bodies — lose recurring reporting streams (DHCS and other departmental reports are repealed), reducing information available for fiscal and program oversight unless replaced by other mechanisms.

Key Issues

The Core Tension

The central dilemma is between flexibility and accountability: SB 144 prioritizes rapid, centralized decisionmaking and event‑specific flexibility (temporary licensure, streamlined CDPH immunization authority, fast funding mechanisms) to meet operational needs, but those same changes reduce procedural safeguards, transparency, and traditional oversight mechanisms—forcing a trade‑off between speed and public accountability that agencies, providers, and legislators will need to manage.

SB 144 combines temporary emergency‑style exceptions designed for an international event with durable shifts in administrative authority and funding pathways. Giving CDPH authority to modify immunization recommendations without full APA rulemaking accelerates state responsiveness but reduces the formal public comment and regulatory vetting that rulemaking provides; it also raises the possibility that California’s guidance will diverge from federal public‑health agencies, producing mismatches between state practice, federal funding conditions, and national advisory recommendations.

Where Medi‑Cal or federal approvals are required, the bill properly conditions state action on federal participation, but operationalizing those contingencies will require tight coordination between CDPH, DHCS, and federal agencies to avoid coverage gaps or billing denials.

The Olympic/Olympiad licensing carve‑outs and EMS authorizations solve an immediate staffing and access problem for a short period, but they also create oversight and continuity‑of‑care risks: temporary practitioners operate under a limited exemption window and may not be integrated into California’s follow‑up systems, complicating liability, records transfer, and post‑event patient care. The statutory good‑faith liability shield for authorized EMS providers reduces malpractice exposure for event care but may limit remedies for injured patients if not carefully reconciled with malpractice law.

On fiscal matters, moving lab and tissue bank fees to a department‑set cost‑recovery model and increasing genetic counselor fee caps will produce more predictable fee recovery for the department but could shift costs to small labs and specialized providers. The Abortion Access Fund’s temporary transfer mechanism fills an access financing gap but raises transparency and accountability questions: transfers are ordered administratively, and grant/contract distributions from the fund are exempted from public disclosure, which will complicate audit trails and public oversight.

Finally, the bill repeals numerous reporting requirements, which streamlines agency burden but may hinder legislative oversight and limit public visibility into program performance.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.